TABLE 3.
n/Total n | HR (95% CI) per 20-nmol/L increase in serum 25(OH)D (age, sex, and month adjusted) | P | HR (95% CI) per 20-nmol/L increase in serum 25(OH)D (age, sex, month, and multivariable adjusted)2 | P | |
All | 2776/14,641 | 0.89 (0.86, 0.93) | <0.0001 | 0.92 (0.88, 0.96) | <0.0001 |
By sex | |||||
Men | 1589/6486 | 0.89 (0.85, 0.94) | <0.0001 | 0.92 (0.87, 0.97) | 0.001 |
Women | 1187/8187 | 0.89 (0.84, 0.94) | <0.0001 | 0.92 (0.86, 0.98) | 0.011 |
By age | |||||
<65 y | 618/8578 | 0.88 (0.81, 0.94) | <0.0001 | 0.92 (0.85, 0.99) | 0.038 |
≥65 y | 2158/6060 | 0.90 (0.86, 0.94) | <0.0001 | 0.92 (0.88, 0.97) | 0.001 |
Excluding early deaths | |||||
Excluding deaths ≤2 y | 2597/14,459 | 0.90 (0.87, 0.93) | <0.0001 | 0.92 (0.89, 0.97) | <0.0001 |
Excluding deaths ≤5 y | 2135/13,997 | 0.91 (0.88, 0.95) | <0.001 | 0.94 (0.89, 0.98) | <0.001 |
By smoking status | |||||
Current smokers | 339/1332 | 0.89 (0.81, 0.98) | 0.018 | 0.90 (0.80, 1.01) | 0.066 |
Current nonsmokers | 2442/13,347 | 0.91 (0.87, 0.94) | <0.0001 | 0.93 (0.89, 0.97) | 0.001 |
By BMI | |||||
<27 kg/m2 | 1496/8557 | 0.89 (0.85, 0.94) | <0.0001 | 0.92 (0.87, 0.97) | 0.002 |
≥27 kg/m2 | 1267/6057 | 0.91 (0.86, 0.96) | <0.001 | 0.93 (0.88, 0.99) | 0.030 |
By physical activity | |||||
Physically inactive | 1042/3641 | 0.88 (0.83, 0.93) | <0.0001 | 0.90 (0.84, 0.97) | 0.003 |
Not physically inactive | 1734/10,093 | 0.92 (0.88, 0.967 | <0.001 | 0.94 (0.89, 0.98) | 0.009 |
Excluding persons with a history of heart disease, stroke, cancer, diabetes, or fracture | 1872/11,676 | 0.90 (0.86, 0.93) | <0.001 | 0.92 (0.88, 0.96) | <0.001 |
Excluding persons with history of asthma or bronchitis | 2284/12,463 | 0.90 (0.87, 0.93) | <0.0001 | 0.92 (0.89, 0.96) | <0.001 |
By social class | |||||
Nonmanual social class | 1695/9067 | 0.88 (0.84, 0.93) | <0.0001 | 0.91 (0.86, 0.95) | <0.0001 |
Manual social class | 1001/5318 | 0.92 (0.87, 0.98) | 0.008 | 0.95 (0.88, 1.01) | 0.12 |
By vitamin supplement use | |||||
No vitamin supplement use | 1177/6604 | 0.91 (0.86, 0.96) | <0.0001 | 0.92 (0.86, 0.98) | 0.007 |
Any vitamin supplement use | 1421/7317 | 0.90 (0.85, 0.95) | <0.0001 | 0.93 (0.87, 0.98) | 0.010 |
By dietary calcium intake | |||||
<1000 mg/d | 1302/6754 | 0.91 (0.86, 0.96) | 0.02 | 0.93 (0.87, 0.99) | 0.02 |
≥1000 mg/d | 1284/5628 | 0.88 (0.84, 0.93) | <0.0001 | 0.91 (0.86, 0.97) | 0.004 |
Conversion factors for nanomoles per liter to nanograms per milliliter were as follows: for 25(OH)D3, divide nanomoles per liter by 2.496 to obtain nanograms per milliliter; for 25(OH)D2, divide 25(OH)D2 by 2.42 to obtain nanograms per milliliter. As a general approximation, multiply nanomoles per liter by 0.4 to obtain nanograms per milliliter (30 nmol/L = 12 ng/mL, 50 nmol/L = 20 ng/mL, 70 nmol/L = 28 ng/mL, 90 nmol/L = 36 ng/mL, and 120 nmol = 48 ng/mL). EPIC-Norfolk, European Prospective Investigation into Cancer and Nutrition–Norfolk; 25(OH)D, 25-hydroxyvitamin D.
Further adjusted for BMI, cigarette smoking, alcohol intake, plasma vitamin C, physical activity, diabetes, history of cardiovascular disease, history of cancer, social class, and educational level (except where the variable was used for stratification). Numbers do not always add up to total because of missing data.